Search results - 66 results
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
Publication Type: Peer reviewed scientific article Authors: Ingrao, Fiona; Ngabirano, Eva; Rauw, Fabienne; Dauphin, Gwenaëlle; Bénédicte Lambrecht * Source: Vaccine (2024) Abstract: The application ...
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.
Publication Type: Peer reviewed scientific article Authors: Valentin, Julie; Ingrao, Fiona; Rauw, Fabienne; Bénédicte Lambrecht * Source: Vaccine, Volume 42, Issue 7, Number 1497 (2024) Abstract: H5 ...
Regulatory workshop on challenge strain development and GMP manufacture- A stakeholder meeting report.
Influenza Vaccines Influenza, Human Viruses Abstract: Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project, a regulatory workshop was organised on the development and manufacture of ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Paula; Bennett, Charlene; Domegan, Lisa; Kalaveshi, Arijana; Jakupi, Xhevat; Ovliyakulova, Gurbangul; Korsun, Neli; Vladimirova, Nadezhda Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) ...
Interim 2022/23 influenza vaccine effectiveness: six European studies, October 2022 to January 2023.
ADOLESCENT Adult Case-Control Studies Child denmark Humans Influenza A Virus, H1N1 Subtype Influenza A Virus, H3N2 Subtype Influenza B virus Influenza Vaccines Influenza, Human Male middle aged Seasons ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Joana Gomes Dias; Sonja J Olsen Source: Euro Surveill, Volume 28, Issue 4 (2023) Keywords: Aged Antiviral Agents Enzyme Inhibitors Guanidines Hospital Mortality Humans Influenza, Human Neuraminidase ...
Whole-Genome Sequence Approach and Phylogenomic Stratification Improve the Association Analysis of Mutations With Patient Data in Influenza Surveillance.
Nancy Roosens Source: Front Microbiol, Volume 13 (2022) Abstract: Each year, seasonal influenza results in high mortality and morbidity. The current classification of circulating influenza viruses is ...
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
chronic disease (OR a 0.22 (95% CI 0.08–0.62)), having received an mRNA-type vaccine (OR a 5.38 (95% CI 1.72–16.80)), and having received an influenza vaccine in 2020–2021 (OR a 3.79 (95% CI 1.30–11.07)). ...
The Expression of Hemagglutinin by a Recombinant Newcastle Disease Virus Causes Structural Changes and Alters Innate Immune Sensing.
NDV-vectored vaccines expressing the immunogenic H5 hemagglutinin (rNDV- H5) are considered attractive candidates to protect poultry from both highly pathogenic avian influenza (HPAI) and Newcastle disease (ND). ...